|
|
Article: U.S. FDA Licenses CSL Biotherapies' New U.S. Influenza Vaccine Filling and Packaging Facility in Illinois.
- Article from:
- Vaccine Weekly
- Article date:
- September 2, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced that the U.S. Food and Drug Administration (FDA) has licensed the company's newest vaccine filling and packaging facility, located in Kankakee, Ill. The facility, part of an investment to expand CSL's U.S. influenza vaccine production capabilities, includes a high-speed, single-dose vaccine syringe filling line (see also CSL Biotherapies).
The primary function of the Kankakee facility is to provide filling and packaging services for CSL Biotherapies' influenza vaccine supply to the U.S. market. That supply is manufactured in Australia. CSL ...